BATH TREATMENT, AN ALTERNATIVE METHOD FOR THE ADMINISTRATION OF THE QUINOLONES FLUMEQUINE AND OXOLINIC ACID TO HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS, AND IN-VITRO ANTIBACTERIAL ACTIVITY OF THE DRUGS AGAINST SOME VIBRIO SP

Citation
Ob. Samuelsen et Bt. Lunestad, BATH TREATMENT, AN ALTERNATIVE METHOD FOR THE ADMINISTRATION OF THE QUINOLONES FLUMEQUINE AND OXOLINIC ACID TO HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS, AND IN-VITRO ANTIBACTERIAL ACTIVITY OF THE DRUGS AGAINST SOME VIBRIO SP, Diseases of aquatic organisms, 27(1), 1996, pp. 13-18
Citations number
32
Categorie Soggetti
Veterinary Sciences","Marine & Freshwater Biology
ISSN journal
01775103
Volume
27
Issue
1
Year of publication
1996
Pages
13 - 18
Database
ISI
SICI code
0177-5103(1996)27:1<13:BTAAMF>2.0.ZU;2-V
Abstract
Administration of flumequine and oxolinic acid to halibut Hippoglossus hippoglossus by bath resulted in significant tissue levels of both th e antibacterials. Bath treatment using 150 mg l(-1) of flumequine and 200 mg l(-1) of oxolinic acid for 72 h resulted in flumequine concentr ations of 14.2 mu g g(-1) in muscle and 85.4 mu g g(-1) in abdominal o rgan homogenate and oxolinic acid concentrations of 9.4 mu g g(-1) in muscle and 72.6 mu g g(-1) in abdominal organ homogenate. Excretion of both antibacterials was rapid and characterised by elimination half-l ives (t(1/2)) of 10 and 15.6 h respectively for flumequine and oxolini c acid in muscle and 9.8 and 15.0 h respectively in the abdominal orga n homogenate. The corresponding elimination times (E(t)) were 6.5 and 8 d respectively for flumequine and oxolinic acid in muscle and 7.5 an d 9 d respectively in abdominal organ homogenate when a maximum residu e concentration of 0.05 mu g g(-1) was applied for both drugs. The min imum inhibitory concentration (MIG) against strains of Vibrio sp. rang ed from 0.015 to 1.0 mu g ml(-1) for flumequine and 0.015 to 0.5 mu g ml-l for oxolinic acid. Following bath treatment, tissue levels of flu mequine and oxolinic acid greater than MIC for susceptible strains (<0 .0625 mu g ml(-1)) were maintained for up to 6.5 and 8 d respectively for flumequine and oxolinic acid in muscle and 7.5 and 9 d respectivel y in abdominal organ homogenate.